Sterile-barrier evidence: separate packaging integrity from shelf-life claims
For the acquired sterile-device submission context, FDA asks for a description of the sterile barrier, how it maintains sterility and package test methods. That is a concrete packaging task. It does not establish a shelf life: aging, product stability and distribution conditions must be scoped separately against the actual product and claim.
Evidence retrieved 2026-10-06. Source versions and topic-specific limits are listed below.
Sourced criteria · US
What changes the service scope?
Decision or task
What the source describes
What to prepare
Which sterile-device context is covered?
The cited guidance has a defined terminal-sterilization/510(k) scope and exclusions. [1]
Record the device, sterile claim and process before applying its packaging recommendation.
Which package and process are being evaluated?
The same guidance discusses sterilization method/site information alongside packaging evidence. [2][3]
Describe package materials, seals, configuration and sterilization exposure; define representative configurations and relevant changes with the specialist.
What does the packaging recommendation actually ask for?
The packaging paragraph asks for a sterile-barrier description, how it maintains sterility and package test methods; it distinguishes these from package test data in that submission context. [3]
Scope integrity and maintenance-of-sterility evidence and a documented method rationale; separate the underlying validation evidence from submission presentation.
What remains unresolved for a shelf-life or transport claim?
The cited packaging paragraph does not itself provide a validated shelf life or a universal aging/distribution protocol. [3]
Identify the claimed duration, storage, transport exposures and product changes, then commission a separately justified stability/aging/distribution plan.
This is a bounded comparison of one FDA packaging recommendation and its scope. Current standards/editions, complete aging/transport methods, pass/fail criteria and supported shelf life are not determined.
A scoped evidence and handoff plan
Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.
Which sterile-device context is covered?
Record the device, sterile claim and process before applying its packaging recommendation.
Useful evidence: Device/claim description and submission/process scope.
Which package and process are being evaluated?
Describe package materials, seals, configuration and sterilization exposure; define representative configurations and relevant changes with the specialist.
Useful evidence: Package drawings/materials, process exposure and configuration/change matrix.
What does the packaging recommendation actually ask for?
Scope integrity and maintenance-of-sterility evidence and a documented method rationale; separate the underlying validation evidence from submission presentation.
Useful evidence: Barrier/function description, methods and underlying validation evidence index.
What remains unresolved for a shelf-life or transport claim?
Identify the claimed duration, storage, transport exposures and product changes, then commission a separately justified stability/aging/distribution plan.
Useful evidence: Shelf-life claim, storage/distribution profile and a product-specific evidence-plan rationale.
Work packages and dependencies
Conditional: Package integrity, aging and distribution scope with justified methods — For this work package, agree the supported criteria, evidence access, covered entities/products and unresolved facts in the table above. Additional services require their own justified scope.
Optional: Separate sterilization-process evidence where relevant — For this work package, agree the supported criteria, evidence access, covered entities/products and unresolved facts in the table above. Additional services require their own justified scope.
Questions for providers
Which exact actor, product or processing facts support the quoted scope, and what is still unresolved?
How will the listed records reach the responsible people, and who owns each change or authority request?
Which tasks and entities are excluded from the agreement, and which additional services need a separate assessment?
Sources and data dates
Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.
